Streetbeat News

Products Services

ENVB

Enveric Biosciences has filed a provisional patent application for AI-based computational methods for identifying and optimizing novel tryptamine derivatives. This move could potentially lead to the development of new therapeutic solutions.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:06 pm

LYEL

Cellares and Lyell are partnering to evaluate the automated manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle Platform. The partnership aims to improve the production process of the therapy.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 12:05 pm

BSEM

NBY

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) and BioStem Technologies, Inc. (OTC:BSEM) have announced an agreement where NovaBay has been granted the right to commercialize BioStem Technologies' Amniotic Tissue Allograft. The product is intended for use as a protective covering during the repair of ocular surfaces.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:05 pm

CATX

Perspective Therapeutics presented preclinical data from two independent studies at the World Molecular Imaging Congress. The studies show the potential of lead-based targeted alpha particle therapy using VMT-α-NET for neuroendocrine tumors. The administration of fractionated doses of [212Pb]VMT-α-NET shows 100% survival in a robust model of metastatic neuroblastoma.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:05 pm

ARDX

Ardelyx has presented data on Ibsrela (Tenapanor) at the 2023 Gastroenterology & Hepatology Advanced Practice Providers Annual Conference. The FDA has approved Ibsrela for the treatment of Irritable Bowel Syndrome with constipation in adults.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:02 pm

LFLY

Leafly Holdings Inc. (NASDAQ:LFLY) is undergoing a strategic shift from a cannabis news agency to a marketplace and education platform. The company's CCO, Carlos Pinto, highlighted their recent partnership with GetGreenlane and the importance of education-focused content for consumers. Pinto also discussed the potential reclassification of cannabis from Schedule I to Schedule III by the Department of Health and Human Services (HHS), expressing cautious optimism about the regulatory shift and its implications for the industry.

Portfolio Pulse from Nicolás Jose Rodriguez

September 11, 2023 | 11:59 am

AAPL

Apple Inc's upcoming iPhone 15 Pro models are expected to be up to 10% lighter than the iPhone 14 Pro due to a change in materials used. The base model iPhone 15 will retain similar dimensions and weight to its predecessor. The iPhone 15 Pro and Pro Max models are expected to cost at least $100 more than the current models. The iPhone 15 series is set to launch globally this month. However, Apple's value dropped by $190B in just two days due to competition threats and a limited ban in China.

Portfolio Pulse from Benzinga Neuro

September 11, 2023 | 11:53 am

MRK

Merck's new analyses of Sotatercept from Phase 3 STELLAR study for Pulmonary Arterial Hypertension showed that treatment with Sotatercept for 24 weeks with background therapy reduced right heart size and improved right-ventricular function, hemodynamic status.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 11:50 am

IRBT

iRobot Corporation has launched two new robot models, Roomba Combo j9+ robot vacuum and mop and Roomba Combo j9+ robot vacuum. The models include a new Clean Base Auto-Fill Dock that automatically empties debris and replenishes the robot with liquid. The company also introduced iRobot OS 7.0, to enhance cleaning automation with Dirt Detective and SmartScrub technologies. IRBT shares closed lower by 2.26% at $36.34 on Friday.

Portfolio Pulse from Shivani Kumaresan

September 11, 2023 | 11:43 am

AAPL

T

TMUS

VZ

KeyBanc Capital Markets analyst John Vinh expects the iPhone 15 to represent a meaningful upgrade cycle from a features perspective. However, he predicts a 4% YoY decrease in builds in the second half due to lower CIS yields at supply chain partner Sony. Reports suggest a $200 price increase for the Pro Max model and a $100 increase for the Pro variant, which Vinh believes could lead to modest demand destruction toward high-end devices. He also noted that T-Mobile US, Inc. and AT&T, Inc. aggressively promoted the iPhone 14, while Verizon, Inc. offered only an 'iPhone 14 on US' to new customers.

Portfolio Pulse from Shanthi Rexaline

September 11, 2023 | 11:39 am